HS Code 30024122.0 — Vaccines for human medicine (COVID-19 etc.)
Chapter 30 (Pharmaceutical Products) · Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products) · Last updated: April 2026 · Source: Indian Customs (DGFT) Records
HS Code 30024122.0 (Vaccines for human medicine (COVID-19 etc.)) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $1.2M across 45 shipments, this code covers 1 distinct pharmaceutical products exported by 5 Indian manufacturers to 10 countries. The leading product under this classification is Vaccine at $1.2M, followed by .
The top importing markets include Pakistan, Nigeria, Bangladesh. The top 5 products account for 100.0% of total trade under this code. Average transaction value is $27.4K. Leading exporters include GLAXOSMITHKLINE BIOLOGICALS SA and SANOFI PASTEUR. Data sourced from Indian Customs (DGFT) shipping bill records.
Products Exported Under HS Code 30024122.0
1 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Vaccine | $1.2M | 45 | $0.98 | 2 |
Import Destinations — HS Code 30024122.0
10 countries import products classified under HS Code 30024122.0 from India
Indian pharmaceutical exports under HS Code 30024122.0 reach 10 countries worldwide. The largest importer is Pakistan ($88.1M), followed by Nigeria ($84.5M), Bangladesh ($78.1M), Kenya ($55.9M). This geographic spread reflects India's position as the world's largest supplier of generic pharmaceutical products by volume.